The latest research study “Pediatric Vaccines Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027” by IMARC Group, finds that the global pediatric vaccines market is expected to exhibit a CAGR of 8.50% during 2022-2027.
Pediatric vaccines or immunizations refer to the medical supplies that create immunity in children, infants, and adolescents. They are utilized for the treatment, prevention, and management of diseases and are typically available in monovalent and multivalent variants. Pediatric vaccines are commonly used in cardiology, critical care, oncology, and pulmonology departments. They assist in protecting children from various serious illnesses, such as measles, brain swelling, polio, paralysis, diarrhea, and hepatitis. Pediatric vaccines are effective, promote a healthier life, are safe, and protect against infectious or noninfectious diseases.
Request a Free PDF Sample for more detailed market insights: https://www.imarcgroup.com/pediatric-vaccines-market/requestsample
Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.
Pediatric Vaccines Market Trends and Drivers:
The escalating prevalence of several chronic diseases is among the primary factor driving the pediatric vaccines market. Besides this, the development of effective and safe vaccination that eliminates and decreases dangerous illnesses that spread from child to child is further augmenting the market growth. Moreover, the introduction of new pediatric vaccines that aid in the treatment of adolescents and children with relapsing forms of multiple sclerosis (RMS) is also catalyzing the global market. Apart from this, the increasing need to promote public health and the extensive product utilization as a cost-effective means of advancing welfare across countries are acting as significant growth-inducing factors. Additionally, the elevating demand for conjugate vaccines that consist of antigens and have the ability to elicit immunological memory and reduce the asymptomatic carriage of the bacteria is also stimulating the market growth. Furthermore, the growing awareness toward early disease diagnosis and prevention, rising research and development (R&D) activities, and the launch of several policies by the government bodies to facilitate accurate and timely vaccination administration are anticipated to propel the pediatric vaccines market over the forecasted period.
Pediatric Vaccines Market 2022-2027 Analysis and Segmentation:
Competitive Landscape:
The competitive landscape of the market has been studied in the report with the detailed profiles of the key players operating in the market.
Abbott Laboratories, Bio-Med Private Limited, Daiichi Sankyo Company Limited, GSK plc, Indian Immunologicals Limited (National Dairy Development Board), Merck & Co. Inc., Mitsubishi Tanabe Pharma Corporation (Mitsubishi Chemical Holdings Corporation), Panacea Biotec Limited, Pfizer Inc., Sanofi S.A. and Sinovac Biotech Ltd.
The report has segmented the market on the basis of type, technology and application.
Breakup by Type:
- Multivalent
- Monovalent
Breakup by Technology:
- Conjugate
- Live Attenuated
- Inactivated
- Subunit
- Toxoid
- Others
Breakup by Application:
- Infectious Disease
- Cancer
- Allergy
- Others
Breakup by Region:
- North America: (United States, Canada)
- Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
- Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
- Latin America: (Brazil, Mexico, Others)
- Middle East and Africa
Key highlights of the report:
- Market Performance (2016-2021)
- Market Outlook (2022- 2027)
- Porter’s Five Forces Analysis
- Market Drivers and Success Factors
- SWOT Analysis
- Value Chain
- Comprehensive Mapping of the Competitive Landscape
If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.
Contact Us:
IMARC Services Private Limited.
30 N Gould St Ste R
Sheridan, WY 82801 USA – Wyoming
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800
About Us:
IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.
IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.
